Ipca Laboratories Market Cap

Ipca Laboratories has a market cap or net worth of 379.08 billion as of March 6, 2026. Its market cap has increased by 0.22% in one year.

Market Cap

379.08B

Enterprise Value

393.71B

Revenue

95.06B

Ranking

n/a

PE Ratio

41.25

Stock Price

1,494.20

Market Cap Chart

Since June 12, 2002, Ipca Laboratories's market cap has increased from 3.22B to 379.08B, an increase of 11,677.39%. That is a compound annual growth rate of 22.24%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	379.08B	5.31%
Dec 31, 2025	359.98B	-16.30%
Dec 31, 2024	430.08B	52.29%
Dec 29, 2023	282.41B	32.03%
Dec 30, 2022	213.90B	-22.18%
Dec 31, 2021	274.86B	-1.01%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Ajanta Pharma	364.21B
Gland Pharma	281.47B
Emcure Pharmaceuticals	278.11B
Laurus Labs	556.38B
Glenmark Pharmaceuticals	575.60B
Alkem Laboratories	653.60B
Wockhardt	209.66B
Piramal Pharma	202.24B

Market Cap Rankings